Mediclinic International PLC
LSE:MDC

Watchlist Manager
Mediclinic International PLC Logo
Mediclinic International PLC
LSE:MDC
Watchlist
Price: 501 GBX Market Closed
Market Cap: £3.7B

EV/IC

0.8
Current
No historical data
Comparison unavailable

Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.

EV/IC
0.8
=
Enterprise Value
GBX5.8B
/
Invested Capital
£6.8B

Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.

EV/IC
0.8
=
Enterprise Value
GBX5.8B
/
Invested Capital
£6.8B

Valuation Scenarios

Mediclinic International PLC is trading above its 3-year average

If EV/IC returns to its 3-Year Average (0.8), the stock would be worth GBX501 (0% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-100%
Maximum Upside
No Upside Scenarios
Average Downside
50%
Scenario EV/IC Value Implied Price Upside/Downside
Current Multiple 0.8 GBX501
0%
3-Year Average 0.8 GBX501
0%
5-Year Average 0.8 GBX501
0%
Industry Average 0 GBX2.47
-100%
Country Average 0 GBX1.77
-100%

Forward EV/IC
Today’s price vs future invested capital

Not enough data available to calculate forward EV/IC

Peer Comparison

All Multiples
EV/IC
P/E
All Countries
Close

Market Distribution

Higher than 92% of companies in United Kingdom
Percentile
92st
Based on 2 035 companies
92st percentile
0.8
Low
0 — 0
Typical Range
0 — 0
High
0 —
Distribution Statistics
United Kingdom
Min 0
30th Percentile 0
Median 0
70th Percentile 0
Max 141.2

Mediclinic International PLC
Glance View

Market Cap
3.7B GBX
Industry
Health Care

Mediclinic International PLC is a fascinating entity in the healthcare sector, with roots deeply planted in South Africa, yet boasting branches that extend into Namibia, Switzerland, and the Middle East. Founded in 1983, Mediclinic has grown over the decades into a reputable provider of private hospital services, focusing on delivering clinical excellence and patient-centered care. Its operations span hospitals, day clinics, and outpatient facilities, which complement one another in creating a comprehensive healthcare network. This synergy allows Mediclinic to cater to various health needs, from simple outpatient procedures to complex surgical interventions, ensuring patients receive holistic and continuous care. The financial heartbeat of Mediclinic stems from its diversified geographical presence and the broad spectrum of services it offers, effectively mitigating risks due to economic or regulatory shifts in any single market. Revenue generation primarily relies on patient fees, encompassing accommodations, medical treatments, and specialist services within their healthcare facilities. Additionally, Mediclinic's strategic investments in cutting-edge medical technology and infrastructure enhance their ability to attract top-tier medical professionals, ensuring that they maintain competitive service offerings in all their regions. As the company navigates the intricacies of varying healthcare systems and legislation, it remains committed to expanding its footprint sustainably while upholding the highest standards in medical practice.

MDC Intrinsic Value
Not Available
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett